Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Assessment of outcome predictors after first attack of optic neuritis.
Mamarabadi M, Razjouyan H, Mohammadi F, Moghaddasi M.
Can J Neurol Sci. 2011 Nov;38(6):887-95.
Related citations
Complications in MS patients after CCSVI procedures abroad (Calgary, AB).
Burton JM, Alikhani K, Goyal M, Costello F, White C, Patry D, Bell R, Hill MD.
Can J Neurol Sci. 2011 Sep;38(5):741-6.
Impact of the cognitive status on the memory complaints in MS patients.
Demers M, Rouleau I, Scherzer P, Ouellet J, Jobin C, Duquette P.
Can J Neurol Sci. 2011 Sep;38(5):728-33.
Safety, not only efficacy still to be proven for controversial new MS treatment.
Kremenchutzky M.
Can J Neurol Sci. 2011 Sep;38(5):667-8. No abstract available.
Loss of purkinje cells is associated with demyelination in multiple sclerosis.
Giuliani F, Catz I, Johnson E, Resch L, Warren K.
Can J Neurol Sci. 2011 May;38(3):529-31. No abstract available.
Adherence to multiple sclerosis disease-modifying therapies in Ontario is low.
Wong J, Gomes T, Mamdani M, Manno M, O'Connor PW.
Can J Neurol Sci. 2011 May;38(3):429-33.
The toronto observational study of natalizumab in multiple sclerosis.
Krysko KM, O'Connor PW.
Can J Neurol Sci. 2011 May;38(3):422-8.
Meaningful change in cognition in multiple sclerosis: method matters.
Walker LA, Mendella PD, Stewart A, Freedman MS, Smith AM.
Can J Neurol Sci. 2011 Mar;38(2):282-8.
Head pre-cooling improves symptoms of heat-sensitive multiple sclerosis patients.
Reynolds LF, Short CA, Westwood DA, Cheung SS.
Can J Neurol Sci. 2011 Jan;38(1):106-11.
Ultraviolet radiation (UVR) and risk of developing multiple sclerosis (MS).
Warren S, Warren KG, Turpin KV.
Can J Neurol Sci. 2011 Jan;38(1):6-7. No abstract available.
Corpus callosum atrophy in a patient with neuromyelitis optica.
Alikhani K, Lee DH, Kremenchutzky M.
Can J Neurol Sci. 2011 Jan;38(1):165-7. No abstract available.
A quantitative analysis of suspected environmental causes of MS.
Sloka S, Silva C, Pryse-Phillips W, Patten S, Metz L, Yong VW.
Can J Neurol Sci. 2011 Jan;38(1):98-105.
Multiple sclerosis - a vascular etiology?
Weir B.
Can J Neurol Sci. 2010 Nov;37(6):745-57. Review.
CCSVI: hope, hype or snake oil?
Oger J, Alkhawajah M.
Can J Neurol Sci. 2010 Nov;37(6):716. No abstract available. Erratum in: Can J Neurol Sci. 2011 Mar;38(2):379. Alkhajawah, Mona [corrected to Alkhawajah, Mona].
Corpus callosum volume and interhemispheric transfer in multiple sclerosis.
Brown LN, Zhang Y, Mitchell JR, Zabad R, Metz LM.
Can J Neurol Sci. 2010 Sep;37(5):615-9.
Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients.
Akbar N, Lobaugh NJ, O'Connor P, Moradzadeh L, Scott CJ, Feinstein A.
Can J Neurol Sci. 2010 Sep;37(5):608-14.
Brain, cognition and MRI in MS: an ongoing refinement process.
Jobin C, Duquette P.
Can J Neurol Sci. 2010 Sep;37(5):551-2. No abstract available.
Inverse vaccination to silence immunity to myelin in multiple sclerosis.
Steinman L.
Can J Neurol Sci. 2010 Sep;37 Suppl 2:S49-58.
New directions in multiple sclerosis therapy: matching therapy with pathogenesis.
Antel J.
Can J Neurol Sci. 2010 Sep;37 Suppl 2:S42-8.
The human microbiome in multiple sclerosis: pathogenic or protective constituents?
Power C, Antony JM, Ellestad KK, Deslauriers A, Bhat R, Noorbakhsh F.
Can J Neurol Sci. 2010 Sep;37 Suppl 2:S24-33. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on